Skip to content

Investigating effect of Spirulina dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units

Investigating effect of Spirulina (Arthrospira platensis) dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units of hospitals: phase 2 clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200720048139N1
Enrollment
138
Registered
2020-11-09
Start date
2020-11-21
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. ?????? ?????-19 ????? ??? ?? ?????? ??????????

Interventions

Intervention group: COVID-19 patients hospitalized in ICU.

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All covid-19 patients confirmed with PCR test admitted to the ICU are entered the trial

Exclusion criteria

Exclusion criteria: Age less than 18 Women during pregnancy and lactation Consumers of supplements C, E, Omega 3, Antioxidants in the last 3 months Patients with severe renal failure Patients with liver failure last stage (cirrhosis) Patients with uncontrolled hypertension Patients who do not have a functioning gastrointestinal tract and have not been prescribed oral or intravenous nutrition Patients with drug / food allergies

Design outcomes

Primary

MeasureTime frame
IL6. Timepoint: The first and 28th of the study. Method of measurement: Blood Sample method: ELISA ; sensivity 0.06 pg/ml.;ESR (Erythrocyte sedimentation rate). Timepoint: The first and 28th of the study. Method of measurement: Automated Modified Westergren.;CRP. Timepoint: The first and 28th of the study. Method of measurement: Blood sampling- ELISA.;Nutrition Status. Timepoint: the first and 28th of the study. Method of measurement: Nutric-score Questionnaire.;Fever. Timepoint: Daily. Method of measurement: Digital Thermometer.;O2 SATURATION. Timepoint: Duration the stay in ICU. Method of measurement: Pulse Oxymeter.

Secondary

MeasureTime frame
Duration of Stay in ICU. Timepoint: Since the first day till end of stay in ICU. Method of measurement: OBSERVATION.;Ventilator Free days. Timepoint: During the stay in ICU. Method of measurement: Observation.;Mortality Rate. Timepoint: During the stay in ICU. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonireh Hatami

Islamic Azad University

mhnutr@gmail.com+98 21 2200 2040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 8, 2026